DRMA Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $1.65
Past Year
- $20.29
Growth Past 5yrs
43.22%
Next Quarter
- $1.54
Estimate Next Year
$44.31
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$10.00
681.25% Upside
Mean Price Target
$10.00
681.25% Upside
Lowest Price Target
$10.00
681.25% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
DRMA Earnings Per Share (EPS) History
According to financial reports, DRMA (NYSE: DRMA) reported an actual EPS of $-1.65 for the quarter ending on Nov 14, 2025, compared to an estimated $-1.59, resulting in a 3.77% surprise. In the prior quarter (Aug 13, 2025), DRMA recorded an actual EPS of $-1.66 with a -42.76% surprise. See DRMA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
DRMA has experienced notable EPS surprises, with the latest quarter ending Nov 14, 2025 showing a 3.77% beat. Previously, the quarter ending Aug 13, 2025 recorded a -42.76% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 14, 2025 | -1.65 | -1.59 | +3.77% |
| Aug 13, 2025 | -1.66 | -2.9 | -42.76% |
| May 14, 2025 | -4.5 | -0.45 | +900.00% |
| Mar 17, 2025 | -3.15 | -1.5 | +110.00% |
| Nov 13, 2024 | -2.04 | -2.64 | -22.73% |
| Aug 07, 2024 | -4.18 | -3.79 | +10.29% |
Frequently Asked Questions
Is DRMA stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given DRMA stock an average recommendation of
Buy. 1 analysts have given their ratings
to DRMA out of which
0 analysts have given strong buy call,
1 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$10.00 gives the stock implied upside
of roughly 681.25% over the next year or so.
What have analysts suggested for DRMA highest price target?
Analysts suggest DRMA's stock price would rise to a high of $10.00.
What is the lowest price target analysts expect for DRMA over the next year?
Within the next 12 months, analysts predict the DRMA stock price could move to $10.00.
What is the average target price for DRMA?
DRMA stock has an average analyst estimate of $10.00.
At its current price, how far is DRMA from its average target price?
DRMA shares are currently trading 681.25% above this price target.
What were DRMA’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $1.65 versus consensus estimates of - $1.59, and above the comparable year-ago quarter’s EPS of - $2.04.
What are the current estimates for quarterly and annual earnings per share?
DRMA's forecasts by analysts estimating quarterly EPS at - $1.54 and $44.31 for the whole year.
What has DRMA's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for DRMA in the next five years, compared to growth rates of 43.22% in the past five years.